Regents Of The University Of California Intellia Therapeutics, Inc. Transaction History
Regents Of The University Of California
- $179 Million
- Q2 2024
A detailed history of Regents Of The University Of California transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Regents Of The University Of California holds 117,315 shares of NTLA stock, worth $1.81 Million. This represents 1.47% of its overall portfolio holdings.
Number of Shares
117,315
Previous 117,315
-0.0%
Holding current value
$1.81 Million
Previous $3.23 Million
18.66%
% of portfolio
1.47%
Previous 1.0%
Shares
3 transactions
Others Institutions Holding NTLA
# of Institutions
320Shares Held
88.4MCall Options Held
673KPut Options Held
865K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.3MShares$189 Million2.39% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$148 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.1MShares$140 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.8MShares$74.1 Million3.53% of portfolio
-
State Street Corp Boston, MA4.36MShares$67.3 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.17B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...